A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

Stopped The study was terminated early by the sponsor due to strategic reprioritization reasons.

Conditions

• Respiratory Syncytial Viruses
• Respiratory Tract Diseases

Interventions

• BIOLOGICAL: RSV Vaccine
• BIOLOGICAL: Placebo

Sponsor

Janssen Vaccines & Prevention B.V.